Wave Life Sciences
183 hedge funds and large institutions have $1.59B invested in Wave Life Sciences in 2024 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 76 increasing their positions, 38 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
13% more funds holding
Funds holding: 162 → 183 (+21)
9.58% less ownership
Funds ownership: 93.91% → 84.33% (-9.6%)
Holders
183
Holding in Top 10
4
Calls
$9.23M
Puts
$5.33M
Top Buyers
| 1 | +$25.5M | |
| 2 | +$24.4M | |
| 3 | +$20.5M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$12.4M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$10.7M |
Top Sellers
| 1 | -$24.4M | |
| 2 | -$22.1M | |
| 3 | -$11.6M | |
| 4 |
TPC
Takeda Pharmaceutical Company
Tokyo,
Japan
|
-$11M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$8.41M |